Profile

Inteligex Inc. is a regenerative medicine company focused on improving clinical outcomes for patients with conditions affecting the Central Nervous System (CNS). Inteligex has developed a novel targeted human stem cell platform (ReStaRT) for the treatment of CNS disease. Inteligex is tasked with bringing this novel human stem cell platform to market and clinic for diseases such as Multiple Sclerosis (MS), Stroke, Amyotrophic Lateral Sclerosis (ALS) and our lead indication Spinal Cord Injury (SCI).

Inteligex Inc. logo

Website

inteligexinc.com

Contact


Event details

Date: January 13 - 15, 2025

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

21 in total